Why insider trading matters?
Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-03-15 | Tessmer James F | VP, Finance & Accounting | Sell | 22,912 | $6.92 | $158,440 | Yes |
| 2019-08-02 | Tessmer James F | VP, Finance & Accounting | Buy | 10,000 | $1.14 | $11,400 | No |
| 2018-06-08 | Tessmer James F | VP, Finance & Accounting | Sell | 10,000 | $12.91 | $129,076 | Yes |
| 2016-06-06 | Tessmer James F | VP, Finance & Accounting | Sell | 1,500 | $15.00 | $22,500 | Yes |
| 2016-05-23 | Tessmer James F | VP, Finance & Accounting | Sell | 6,000 | $13.00 | $78,000 | Yes |
Insider Smart
Insider Smart